The Molecular Mechanisms of Bergapten Against Abdominal Aortic Aneurysm: Evidence From Network Pharmacology, Molecular Docking/Dynamics, and Experimental Validation
Journal of Cellular Biochemistry · 2025
DOI: 10.1002/jcb.70029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2025. Verfasst von Fujia Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: This study was supported by the National Natural Science Foundation of China (no. 82260058), Guizhou Provincial Health Commission (no. gzwkj2023-130), Foundati….
Abstract (Originalsprache)
This study endeavors to assess the potential protective role of bergapten (BP) in mitigating abdominal aortic aneurysm (AAA) and to decipher the underlying mechanisms and molecular targets. Network pharmacology was utilized to search for potential targets of BP against AAA. Molecular docking and molecular dynamics simulations were utilized to validate the interaction of BP with core targets, and then the therapeutic effect and mechanism of BP on AAA were verified by using an elastase‐induced AAA model. Network pharmacology analysis identified five pharmacological targets for BP, including EGFR, SRC, PIK3CA, PIK3CB, and JAK2. Molecular docking and molecular dynamics simulations further prioritized JAK2 as the most promising candidate for the potential treatment of AAA. The results of animal experiments demonstrated that BP significantly reduced the expression of inflammatory cytokines IL‐6, TNF‐α, and IL‐1β in the aortic tissue of AAA mouse model, and inhibited the phosphorylation of JAK2 and STAT3. BP plays an important role in the treatment of AAA, and it may become a promising drug to combat AAA progression. The inhibitory effect of BP on AAA vascular progression and the attenuation of inflammatory cell infiltration may be related to the regulation of JAK2/STAT3 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou Medical University, Guiyang, China.
- Department of Emergency Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
- Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Tianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, Chin…
- Department of Cardiology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, China.
- Department of Cardiology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
ORCID-Profile: Tian Li
Förderung
- This study was supported by the National Natural Science Foundation of China (no. 82260058), Guizhou Provincial Health Commission (no. gzwkj2023-130), Foundati…
Zitieren
APA
Xu, F., Luo, S., Huang, Z., Wang, J., Li, T., Zhong, L., & Si, X. (2025). The Molecular Mechanisms of Bergapten Against Abdominal Aortic Aneurysm: Evidence From Network Pharmacology, Molecular Docking/Dynamics, and Experimental Validation. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.70029
Vancouver
Xu F, Luo S, Huang Z, Wang J, Li T, Zhong L, et al. The Molecular Mechanisms of Bergapten Against Abdominal Aortic Aneurysm: Evidence From Network Pharmacology, Molecular Docking/Dynamics, and Experimental Validation. Journal of Cellular Biochemistry. 2025. doi:10.1002/jcb.70029
BibTeX
@article{Xu2025,
author = {Xu, Fujia and Luo, Sihan and Huang, Zhenhua and Wang, Junfen and Li, Tian and Zhong, Lintao and Si, Xiaoyun},
title = {The Molecular Mechanisms of Bergapten Against Abdominal Aortic Aneurysm: Evidence From Network Pharmacology, Molecular Docking/Dynamics, and Experimental Validation},
journal = {Journal of Cellular Biochemistry},
year = {2025},
doi = {10.1002/jcb.70029}
}
EUVIMED